On March 7, 2022 Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, reported that Mike Garrett, Chief Executive Officer, will present at the BioCapital Europe 2022 meeting on March 10th, 2022 at 5pm CET/11am ET (Press release, Flamingo Therapeutics, MAR 7, 2022, View Source;utm_medium=rss&utm_campaign=flamingo-therapeutics-to-present-at-biocapital-europe-2022 [SID1234609578]). The Flamingo management team will also participate in one-on-one meetings with investors during the conference. BioCapital Europe will be taking place in person at Hotel Sofitel Legend The Grand Amsterdam.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe.